Patents | Intellepedia

Patent Attorneys: From Strategic Professionals to Ordinary Vendors? The Changing Soul of India’s Patent Ecosystem

For a long time, patent attorneys occupied an important place in India’s innovation and business ecosystem because they helped companies identify protectable value, convert innovation into legal rights, and build patent portfolios capable of supporting business growth and financial success. Today, that position is changing. As artificial intelligence is reshaping patent work, cost pressures are intensifying, quality concerns are weakening, and regulatory as well as contractual burdens are increasing, the patent attorney is facing a future in which specialised professional standing is giving way to a vendor driven role. If that change continues, it will not only affect patent attorneys, but may also weaken the patent ecosystem itself and its contribution to innovation driven growth, commercialisation, and knowledge based progress.

Amgen’s Lyophilized Peptibody Patent Upheld by Madras High Court

Banner with lab test tubes and a microscope; text reads 'Amgen’s Peptibody Patent Refusal Overturned' following Madras High Court ruling

Madras High Court backs Amgen on lyophilized peptibody formulations, rejecting Section 3(d), 3(e) and inventive step objections. Grant directed, with claims narrowed to supported sequences.

CGPDTM Headquarters Relocated to New Delhi: Official Notification

Headquartes of Indian Patent office relocated to Delhi

The Department for Promotion of Industry and Internal Trade (DPIIT) has announced the relocation of the CGPDTM headquarters to New Delhi, as per the Gazette of India notification dated February 25, 2025. The new office is now operational at Boudhik Sampada Bhawan, Dwarka, New Delhi. This move aims to enhance coordination with central regulatory bodies and improve India’s intellectual property administration.

Indian Patent & Design Statistics Report – 2025

BananaIP’s Indian Patent and Design Statistics Report 2024 highlights a 60% increase in patent publications, a 15% drop in grants, and reduced examination rates. Delhi and Chennai emerge as top contributors to filings, showcasing trends in India’s evolving IP landscape.

Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)

The Madras High Court clarified the interpretation of Section 3c regarding patent eligibility of monoclonal antibodies in India. The Court held that synthetic antibodies may be patentable if they demonstrate novelty or technical advancement.

Generative AI (GenAI), Business and Intellectual Property

This post analyses the challenges and opportunities in protecting and enforcing intellectual property for generative AI inventions. Dr. Kalyan C. Kankanala offers structured guidance on leveraging IP for AI startups within the current legal context.

Draft Patents (2nd Amendment) Rules, 2024

The Draft Indian Patent Rules 2024 outlines new adjudication procedures and clarifies key roles in patent-related disputes. The amendments seek to enhance transparency and efficiency in India’s patent process.

Celebrating New Year IP Growth: A Bright 2024 Ahead

The post outlines significant progress in the Indian intellectual property sector during 2023. It anticipates further growth and innovation in 2024, wishing continued success to all engaged in IP-driven businesses.

Accelerate Your Patent Journey: Join BananaIP’s Discussion Forum on “Getting a Patent in One Year”

BananaIP Counsels invites startups and enterprises to a forum on getting a patent in one year, led by patent experts. The session covers strategies for expediting the patent process and increasing IP value for business growth. Register to gain practical insights from industry leaders.

Patents filed by Young Inventors!

The article examines patents filed by young inventors in India, with detailed examples of child-led innovations and their patent status. It highlights BananaIP’s commitment to supporting young inventors in the patent process, in an objective and structured manner.